
Anebulo Pharmaceuticals Announces New CEO
October 06, 2023 04:06 PM Eastern Daylight Time AUSTIN, Texas – Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB) (“Anebulo”), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication (“ACI”), today announced that Richie Cunningham has been appointed as Anebulo’s Chief Executive Officer, replacing Simon Allen. “Anebulo has positioned ANEB-001 for success and I look forward to working with the leadership team and board … Continue reading Anebulo Pharmaceuticals Announces New CEO